S&P 500
(0.11%) 5 254.21 points
Dow J
(0.00%) 39 762 points
Nasdaq
(0.01%) 16 401 points
Oil
(1.52%) $82.59
Gas
(0.52%) $1.727
Gold
(2.02%) $2 234.80
Silver
(0.97%) $24.99
Platinum
(1.48%) $923.15
USD/EUR
(0.27%) $0.926
USD/NOK
(0.53%) $10.83
USD/GBP
(0.01%) $0.791
USD/RUB
(0.24%) $92.66

Realtime updates for Sumitomo Pharma Co., Ltd. [4506.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated28 Mar 2024 @ 02:15

-1.74% ¥ 396.00

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 02:15):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Sumitomo Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally...

Stats
Today's Volume 2.39M
Average Volume 3.41M
Market Cap 157.33B
EPS ¥0 ( 2024-01-31 )
Next earnings date ( ¥-210.31 ) 2024-05-12
Last Dividend ¥7.00 ( 2023-03-30 )
Next Dividend ¥0 ( N/A )
P/E -0.910
ATR14 ¥0.481 (0.12%)

Volume Correlation

Long: -0.19 (neutral)
Short: 0.95 (very strong)
Signal:(49.253) Expect same movement, but be aware

Sumitomo Pharma Co., Ltd. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sumitomo Pharma Co., Ltd. Correlation - Currency/Commodity

The country flag -0.18
( neutral )
The country flag 0.01
( neutral )
The country flag 0.73
( moderate )
The country flag 0.27
( neutral )
The country flag 0.51
( weak )
The country flag 0.63
( weak )

Sumitomo Pharma Co., Ltd. Financials

Annual 2022
Revenue: ¥555.54B
Gross Profit: ¥376.63B (67.79 %)
EPS: ¥-187.55
Q3 2023
Revenue: ¥82.39B
Gross Profit: ¥49.52B (60.11 %)
EPS: ¥-125.77
Q2 2023
Revenue: ¥76.96B
Gross Profit: ¥47.06B (61.16 %)
EPS: ¥-72.68
Q1 2023
Revenue: ¥75.69B
Gross Profit: ¥45.26B (59.79 %)
EPS: ¥-97.81

Financial Reports:

No articles found.

Sumitomo Pharma Co., Ltd. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥14.00
(N/A)
¥0
(N/A)
¥7.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Sumitomo Pharma Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥4.75 2000-03-28
Last Dividend ¥7.00 2023-03-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 47 --
Total Paid Out ¥382.25 --
Avg. Dividend % Per Year 0.00% --
Score 1.47 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-07-03)
¥6.79 Estimate 3.75 %
Dividend Stability
0.30 Poor
Dividend Score
1.47
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9962.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8977.T Ex Dividend Knight 2023-11-29 Semi-Annually 0 0.00%
8125.T Ex Dividend Knight 2024-02-28 Annually 0 0.00%
7483.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
6752.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
6136.T Ex Dividend Knight 2023-11-29 Semi-Annually 0 0.00%
4887.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4091.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3315.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
2395.T Ex Dividend Junior 2023-09-28 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5261.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.1641.200-5.46-6.56[0 - 0.3]
returnOnEquityTTM-0.4401.500-6.00-9.00[0.1 - 1]
payoutRatioTTM-0.0161-1.000-0.1610.161[0 - 1]
currentRatioTTM0.6270.800-1.864-1.491[1 - 3]
quickRatioTTM0.3330.800-2.75-2.20[0.8 - 2.5]
cashRatioTTM0.08661.500-0.630-0.945[0.2 - 2]
debtRatioTTM0.389-1.5003.52-5.29[0 - 0.6]
interestCoverageTTM-8.871.000-4.40-4.40[3 - 30]
operatingCashFlowPerShareTTM-693.012.00-10.00-10.00[0 - 30]
freeCashFlowPerShareTTM-728.722.00-10.00-10.00[0 - 20]
debtEquityRatioTTM1.199-1.5005.20-7.81[0 - 2.5]
grossProfitMarginTTM0.5991.0003.343.34[0.2 - 0.8]
operatingProfitMarginTTM-0.5361.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.6691.000-4.83-4.83[0.2 - 2]
assetTurnoverTTM0.3120.800-1.256-1.005[0.5 - 2]
Total Score-5.81

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.9101.000-0.1930[1 - 100]
returnOnEquityTTM-0.4402.50-3.86-9.00[0.1 - 1.5]
freeCashFlowPerShareTTM-728.722.00-10.00-10.00[0 - 30]
dividendYielPercentageTTM1.7591.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM-693.012.00-10.00-10.00[0 - 30]
payoutRatioTTM-0.01611.500-0.1610.161[0 - 1]
pegRatioTTM-2.631.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.8341.000-10.000[0.1 - 0.5]
Total Score-4.01

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastrointestinal; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. It also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators